S-1/A: Australian Oilseeds Faces Mounting Losses and Nasdaq Delisting Threats Amidst Strategic Capital Raise and Expansion Efforts
Registration Statement Amendment
Australian Oilseeds Holdings Limited filed an S-1/A registration statement for the resale of up to 25.86 million shares, revealing significant financial losses, a worsening net current liability, and ongoing Nasdaq listing compliance challenges, despite revenue growth and ambitious expansion plans.
Summary
- Australian Oilseeds Holdings Limited, an Australian cold-pressing oil plant, filed an S-1/A registration statement for the resale of up to 25,859,391 Ordinary Shares by selling securityholders, including up to 25,000,000 shares potentially issued to Arena Business Solutions Global SPC II, Ltd. under a Purchase Agreement.
- The company reported a net loss of AUD$1,597,298 for the nine months ended March 31, 2025, a significant decline from a profit of AUD$2,422,104 in the same period last year.
- Gross profit for the nine months ended March 31, 2025, decreased by 47.1% to AUD$2,600,949, compared to AUD$4,918,476 in the prior year period.
- Sales revenue increased by 16.1% to AUD$30,163,944 for the nine months ended March 31, 2025, driven primarily by a 58.2% increase in retail oil sales due to new supply contracts with Costco, Woolworths, and Coles supermarkets in Australia.
- The company's net current liability position worsened to AUD$9,622,311 as of March 31, 2025, from AUD$6,965,530 as of June 30, 2024.
- Net cash outflow from operating activities was AUD$1,942,969 for the nine months ended March 31, 2025, a reversal from an inflow of AUD$1,259,485 in the prior year period.
- Finance expenses surged by 232.7% to AUD$1,280,428 for the nine months ended March 31, 2025, mainly due to repayment of a AUD$4 million asset finance loan and amortization of a convertible note discount.
- The company is constructing a new AUD$25 million multi-seed crushing plant in Emerald, Central Queensland, with funding from government support (AUD$5 million), operating cashflow (AUD$3 million), bank funding (AUD$6-10 million), and equity funding (AUD$8-11 million).
- Australian Oilseeds is facing Nasdaq listing compliance issues, including a minimum bid price requirement ($1.00) and a minimum stockholders' equity requirement ($10 million), with a hearing scheduled for July 22, 2025, regarding the latter.
Sentiment
Score: 3
Explanation: The sentiment is negative due to significant financial losses, a worsening net current liability, negative operating cash flow, and multiple ongoing Nasdaq listing compliance issues that threaten the company's public trading status. While revenue growth in retail oils and expansion plans are positive, the overall financial health and immediate operational challenges present a concerning outlook.
Positives
- Sales revenue increased by 16.1% to AUD$30.16 million for the nine months ended March 31, 2025, compared to AUD$25.99 million in the prior year period.
- Retail oil sales saw substantial growth of 58.2%, reaching AUD$15.63 million for the nine months ended March 31, 2025, driven by new supply contracts with major Australian supermarkets like Costco, Woolworths, and Coles.
- The company secured three supply contracts to supply 15 Costco Australia stores, 1,050 Woolworth Supermarkets national stores, and 850 Coles supermarket stores.
- Cash and cash equivalents increased to AUD$1,435,123 as of March 31, 2025, from AUD$514,140 as of June 30, 2024.
- The company received AUD$5 million in government support (funding and tax credits) for the new Emerald, Queensland facility.
- Net cash provided by financing activities increased to AUD$3,765,870 for the nine months ended March 31, 2025, indicating successful capital raising efforts.
- The company's existing Cootamundra facility expanded with full operations commencing in August 2024, and the new Queensland plant is projected to quadruple total capacity to 160,000 metric tons per annum.
Negatives
- The company reported a net loss of AUD$1,597,298 for the nine months ended March 31, 2025, a significant reversal from a profit of AUD$2,422,104 in the same period last year.
- Gross profit decreased by 47.1% to AUD$2,600,949 for the nine months ended March 31, 2025, despite increased revenue, indicating a squeeze on margins.
- Operating profit turned into a loss of AUD$267,776 for the nine months ended March 31, 2025, compared to a profit of AUD$2,806,963 in the prior year period.
- Finance expenses increased by 232.7% to AUD$1,280,428 for the nine months ended March 31, 2025, primarily due to increased interest expenses and amortization of convertible note discount.
- The company's net current liability position worsened to AUD$9,622,311 as of March 31, 2025, from AUD$6,965,530 as of June 30, 2024, indicating deteriorating short-term liquidity.
- Net cash flow from operating activities shifted from an inflow of AUD$1,259,485 in the nine months ended March 31, 2024, to an outflow of AUD$1,942,969 in the current period.
- Cost of sales increased by 30.8% for the nine months ended March 31, 2025, primarily due to higher material costs (canola seed), packaging, and labor.
- General and administrative expenses increased by 35.3% and selling and marketing expenses increased by 31.2% for the nine months ended March 31, 2025.
Risks
- The company has a history of financial losses, including a net loss of AUD$33,725,100 for the year ended June 30, 2024, and may not achieve or maintain profitability.
- There is substantial doubt about the company's ability to continue as a going concern without additional funding from operations, long-term debt, or equity raises.
- The sale and issuance of Ordinary Shares to Arena under the Purchase Agreement will cause dilution to existing shareholders, and the perception of such sales could depress the stock price.
- The company's stock price may be volatile, and there is a risk of delisting from Nasdaq due to non-compliance with the minimum bid price ($1.00) and minimum stockholders' equity ($10 million) requirements.
- The company is significantly dependent on revenues from the sale of cold-pressed vegetable oils and protein meals, making it vulnerable to market changes in these product lines.
- Lack of product and business diversification makes the company's future revenues and earnings susceptible to fluctuations in the agricultural industry.
- Dependence on contracts with local and regional farmers for oilseeds poses a risk if these contracts are not renewed or if quality/quantity declines.
- A material concentration of revenue from a small group of customers (top five customers accounted for 87.9% of sales for the three months ended March 31, 2025) creates a significant risk if any of these customers are lost.
- The company faces risks from global, federal, state, and local regulations, including trade restrictions, food safety, sustainability, and environmental laws, which could adversely affect operations and financial condition.
- Operations are subject to changing conditions like unfavorable weather (blight, bush fires, drought, flooding) and disruptions in water and power supply, which can affect production and profitability.
- The company's revenue may not achieve budget in FY2025 due to capital expenditures for facility expansion and construction, and potential factory breakdowns or overhauls.
- Failure to effectively promote its brand, especially regarding its GMO-free and chemical-free processes, could harm reputation and demand.
- Inability to hire and retain qualified personnel, particularly key management like Gary Seaton, could adversely affect growth and business objectives.
- The retail price of products may be subject to government price controls, potentially reducing profit margins.
- Adverse publicity related to products, raw materials, or suppliers/customers could harm reputation and financial results.
- Inability to develop new products could adversely affect business and financial condition.
- Geopolitical risks, including the conflict in Ukraine and the Israel-Hamas war, could lead to market disruptions, supply chain interruptions, and inflation, impacting the business.
- The company's management has limited experience in operating a public company, potentially leading to increased costs and time diversion for compliance.
- The business model is capital-intensive, and the inability to raise additional capital on attractive terms could materially and adversely affect operations and prospects.
- Principal shareholders (JSKS Enterprises) have significant influence over corporate actions, potentially delaying or preventing acquisitions.
- Future sales of substantial amounts of Ordinary Shares by the company or existing shareholders could adversely affect the market price.
- The company may redeem unexpired warrants prior to their exercise at a disadvantageous time for warrant holders, potentially forcing early exercise or acceptance of a nominal redemption price.
Future Outlook
The company expects to achieve AUD$2.4 million net profit before tax from July 2025 to June 2026, subject to market and weather conditions. It plans to fund future capital expenditures, working capital, and other cash requirements through operating cash flows, an AUD$8 million unused facility from Commonwealth Bank of Australia, an additional US$6 million from existing PIPE investors via redeemable debentures, or a US$50 million equity line of credit (ELOC). The company aims to become the largest cold-pressed producer in the Oceanic/APAC region by expanding its existing Cootamundra facility and constructing a new multi-seed crushing plant in Emerald, Queensland, which is expected to increase total capacity to 160,000 metric tons per annum.
Management Comments
- Management believes that transitioning from a fossil fuel economy to a renewable and chemical-free economy is the solution to many health problems the world is facing presently.
- The company is committed to working with suppliers and customers to eliminate chemicals from the edible oil production and manufacturing systems to supply quality products such as non-GMO oilseeds and organic and non-organic food-grade oils globally.
- Management has assessed current and pending climate-related legislation and confirmed that the company is not currently subject to, nor does it believe any pending legislation will have, a material impact on the business, capital expenditures, or operating costs.
- The company intends to actively monitor its performance with respect to Nasdaq listing standards and will consider available options to resolve deficiencies and regain compliance.
- Management believes its relationship with its employees and contractors is cooperative and that they share the same goals to industrialize oilseeds and make products available worldwide.
Industry Context
The global oilseeds market was valued at USD$249.05 billion in 2023 and is projected to grow to USD$373.32 billion by 2033, at a CAGR of 4.13%. This growth is driven by increasing usage of oilseeds in animal feed, demand for healthy and organic oilseed-processed goods, and public-private collaborations in varietal development. The non-GMO food market, which Australian Oilseeds targets, was USD$740.65 billion in 2023 and is projected to grow to USD$2,003.68 billion by 2032, at a CAGR of 11.94%, indicating strong consumer preference for such products. Australia's high-quality oilseed output is well-positioned to supply the rapidly expanding Asia-Pacific consumer export markets. The company's expansion plans align with the increasing global demand for sustainable, premium cold-pressed, and non-GMO products.
Comparison to Industry Standards
- The global oilseeds market is projected to grow at a CAGR of 4.13% from 2024 to 2033, while the non-GMO food market is expected to grow at a higher CAGR of 11.94% during the same period, suggesting Australian Oilseeds' focus on non-GMO products aligns with a faster-growing segment.
- The company's expansion of cold-pressing capacity from 40,000 metric tons to an anticipated 160,000 metric tons (four times current capacity) aims to position it as the largest cold-pressed player in the APAC region, indicating an aggressive growth strategy relative to regional competitors.
- The company's reliance on a small group of top customers (87.9% of sales from top five customers for the three months ended March 31, 2025) is a higher concentration than typically seen in diversified food processing industries, increasing customer concentration risk.
- The company's shift to a net loss and negative operating cash flow, despite revenue growth, contrasts with the overall market growth for oilseeds and non-GMO products, suggesting internal operational or cost management challenges.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Financial Officer | Bob Wu | Amarjeet Singh | 2025-02-28 | Bob Wu resigned; Amarjeet Singh appointed. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Controlled Company Status | The company is a controlled company under Nasdaq Stock Market Rules because JSKS Enterprises, its majority shareholder, holds more than 50% of its voting power. This allows the company to elect not to comply with certain corporate governance requirements, such as having a majority independent board or independent compensation/nominating committees. | 2024-03-21 | Reduces certain corporate governance protections for shareholders compared to companies subject to all Nasdaq requirements. The company intends to take advantage of these exemptions. |
| Clawback Policy Adoption | The Board of Directors adopted a compensation clawback policy requiring the company to clawback erroneously awarded incentive compensation from current and former executive officers under specific conditions (e.g., accounting restatement due to material noncompliance). | 2024-04-10 | Enhances corporate accountability and aligns executive compensation with financial reporting accuracy, potentially mitigating risks of financial misconduct. |
| Board Committee Structure | The Board has established an Audit Committee, a Compensation Committee, and a Nominating and Corporate Governance Committee, each comprised solely of independent directors. | 2024-03-21 | Provides independent oversight for key areas like financial reporting, executive compensation, and director nominations, despite the company's controlled status. |
Legal Proceedings
- Two litigation claims filed against the company's subsidiaries, Cowcumbla Investments Pty Ltd. and Cootamundra Oilseeds Pty Ltd., in the Supreme Court of New South Wales, related to a AUD$1.2 million related party loan with a former director, were settled. The amount due was repaid in monthly installments from January to April 2023, with a final settlement payment of AUD$95,000 on June 1, 2023.
- The company does not expect to incur further costs related to the settled litigation.
- The company is subject to foreseeable and unforeseen risks, including potential securities class action litigation, particularly common against companies following a decline in stock price or related to de-SPAC merger transactions, which could result in substantial costs and diversion of management attention.
Related Party Transactions
- A related party loan is owed to JSKS Enterprises Pty Ltd. (trustee of Gary Seaton Family Trust, controlled by CEO Gary Seaton) with a 6% per annum interest rate, repayable within 12 months after year-end, with the remaining principal due after 12 months. As of March 31, 2025, AUD$1,050,825 was current and AUD$3,932,742 non-current.
- A related party loan is owed to Energreen Nutrition Australia Pty Ltd. (controlled by Gary Seaton) with a 6% per annum interest rate, expected to be repaid in full within 12 months after year-end. As of March 31, 2025, AUD$7,161,361 was current and AUD$989,473 non-current.
- An interest-free loan is owed to CQ Oilseeds Pty Ltd. As of March 31, 2025, AUD$59,371 was non-current.
- The company has promissory notes with American Physicians, LLC (shareholders from the Sponsor of EDOC), totaling AUD$1,314,317 as of March 31, 2025 (AUD$1,040,641 current, AUD$273,676 non-current).
- Purchases of seed from Energreen Nutrition Australia Pty Ltd. totaled AUD$7,222,239 for the nine months ended March 31, 2025.
- Sales of meals to Energreen Nutrition Australia Pty Ltd. totaled AUD$4,290,895 for the nine months ended March 31, 2025.
- Management fees paid to Energreen Nutrition Australia Pty Ltd. totaled AUD$264,000 for the nine months ended March 31, 2025.
- The Board approved the conversion of a JSKS loan amounting to AUD$4.9 million into 4,452,479 shares at USD$0.7241 per share, executed on May 22, 2025, to meet the shareholder equity requirement.
Stakeholder Impact
- **Shareholders**: Face significant dilution from the potential issuance of up to 25 million shares to Arena and the conversion of related party loans into equity. The stock price is highly volatile and subject to Nasdaq delisting risks, which could severely impact liquidity and investment value. The company's controlled status limits the influence of minority shareholders.
- **Employees**: The company's growth and expansion plans, including the new Queensland facility, suggest potential for job creation and stability. However, the company's history of losses and going concern doubt could create uncertainty.
- **Customers**: New supply contracts with major supermarkets (Costco, Woolworths, Coles) indicate increased product availability and market penetration. However, the high concentration of revenue from a few key customers poses a risk if these relationships are disrupted.
- **Suppliers (Farmers)**: The company's dependence on local and regional farmers for oilseeds means their continued business is crucial. Sustainable farming practices are promoted, which could benefit environmentally conscious farmers.
- **Creditors**: The company's net current liability position and reliance on additional debt and equity raises for going concern raise concerns for creditors, although existing bank covenants are currently in compliance.
Next Steps
- Regain compliance with Nasdaq's $1.00 minimum bid price requirement by November 24, 2025.
- Attend the Nasdaq Hearings Panel on July 22, 2025, to appeal the delisting determination related to the minimum stockholders' equity requirement.
- Submit supplemental information to the Nasdaq Hearings Panel by July 2, 2025.
- Continue construction of the new multi-seed crushing plant in Emerald, Queensland, with expected completion by December 2026.
- Secure the remaining AUD$8 million to AUD$11 million in equity funding for the Queensland plant, or fund the shortfall from operating cashflow.
- Potentially draw down additional US$6 million from PIPE investors via redeemable debentures or utilize the US$50 million equity line of credit (ELOC).
- Renegotiate the supply contract with Costco in November 2024.
- Work with Woolworth Grocery on the next major review to increase supply and range of oils under future contracts, including a 750mL Good Earth Oil Extra Virgin Vegetable Oil contract in March 2025.
Key Dates
| Date | Description |
|---|---|
| 2022-12-07 | Business Combination Agreement announced between Australian Oilseeds Holdings Limited, EDOC Acquisition Corp., and Australian Oilseeds Investments Pty Ltd. |
| 2022-12-29 | Australian Oilseeds Holdings Limited incorporated as a Cayman Islands exempted company. |
| 2023-01-01 | Cootamundra land lease commenced. |
| 2023-05-30 | Local mediation process held for litigation claims against Cowcumbla Investments Pty Ltd. and Cootamundra Oilseeds Pty Ltd. |
| 2023-06-01 | Payment of AUD$95,000 as final settlement for related party loan litigation claims. |
| 2023-08-23 | Securities Purchase Agreement signed with Arena Investors, LP (PIPE Investors). |
| 2023-10-31 | Amendment No. 1 to Securities Purchase Agreement dated. |
| 2023-12-04 | Amendment No. 2 to Securities Purchase Agreement dated. |
| 2023-12-07 | Amendment No. 2 to Business Combination Agreement dated. |
| 2023-12-14 | Queensland Government awarded AUD$5 million in funding and tax credits for the Emerald facility. |
| 2024-02-14 | Company issued a note for an equipment loan to Commonwealth Bank of Australia for AUD$4,000,000. |
| 2024-02-28 | Amarjeet Singh appointed as Group Chief Financial Officer of AOI; Bob Wu resigned as CFO. |
| 2024-02-29 | Amendment No. 3 to the Securities Purchase Agreement entered into. |
| 2024-03-05 | Purchase Agreement executed with Arena Business Solutions Global SPC II, Ltd. for up to US$50,000,000 of Ordinary Shares. |
| 2024-03-06 | Extraordinary general meeting of EDOC's shareholders held, approving the Business Combination. |
| 2024-03-21 | Business Combination consummated; EDOC merged into Merger Sub, and Australian Oilseeds acquired AOI shares. Company issued two promissory notes to American Physicians, LLC. |
| 2024-03-22 | Ordinary Shares and Company Warrants commenced trading on Nasdaq Global Market under symbols COOT and COOTW. |
| 2024-04-10 | Board of Directors adopted a compensation clawback policy. |
| 2024-05-19 | First quarterly payment of AUD$244,643 for the Secured Bank Loan commenced. |
| 2024-06-01 | Payment agreement entered with Ellenoff Grossman & Schole LLP (EGS) for legal fees related to Business Combination. |
| 2024-08-01 | Full operations commenced in the expanded Cootamundra facility. |
| 2024-08-28 | Company received a letter from Nasdaq regarding non-compliance with the $1 minimum bid price requirement. |
| 2025-01-03 | Nasdaq notified the company that it regained compliance with the $1 minimum bid price requirement. |
| 2025-01-01 | Construction period for the new Emerald, Queensland plant expected to begin. |
| 2025-03-21 | First Promissory Note payment of USD$112,500 plus interest due. |
| 2025-03-31 | End of the nine-month reporting period for the unaudited condensed consolidated financial statements. |
| 2025-05-14 | Company filed Form 12b-25 with the SEC, disclosing inability to file Form 10-Q on time. |
| 2025-05-20 | Arena Investors, LP converted USD$150,000 of debentures into 221,957 shares. |
| 2025-05-22 | JSKS loan of AUD$4.9 million converted to 4,452,479 shares. |
| 2025-05-27 | Company received a written notice from Nasdaq regarding non-compliance with the $1.00 Minimum Bid Price requirement (second notice). |
| 2025-05-30 | Company filed its Quarterly Report on Form 10-Q for the period ended March 31, 2025, regaining compliance with filing obligation. |
| 2025-06-04 | Company received a letter from Nasdaq notifying non-compliance with the minimum stockholders' equity requirement ($10,000,000). |
| 2025-06-06 | Last reported sales price of Ordinary Shares on Nasdaq was US$0.74 per share. |
| 2025-06-11 | Company requested a hearing before the Nasdaq Hearings Panel regarding the delisting determination for stockholders' equity non-compliance. |
| 2025-06-12 | Nasdaq Hearings Panel agreed to consider the company's appeal at an oral hearing. |
| 2025-06-21 | First payment of USD$165,000 plus interest due for the Second Promissory Note. |
| 2025-06-23 | Date of the S-1/A prospectus filing. |
| 2025-07-02 | Deadline for the company to submit supplemental information to the Nasdaq Hearings Panel. |
| 2025-07-22 | Oral hearing before the Nasdaq Hearings Panel regarding stockholders' equity non-compliance. |
| 2025-11-24 | Deadline to regain compliance with Nasdaq's $1 minimum bid price requirement. |
| 2025-12-31 | Cootamundra land lease term ends. |
| 2026-12-31 | Construction period for the new Emerald, Queensland plant expected to end. |
Recommendation
strong sellKeywords
Oilseeds, Cold-pressed oil, Non-GMO, Sustainable food, Protein meal, Australia, SEC filing, S-1/A, Nasdaq listing, Capital raise, Dilution, Financial results, Business combination, Agricultural products, Food processing, Supply chain, Corporate governance, Risk factors
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.